Cooper Companies (COO) | Financial Analysis & Statements

The Cooper Companies Inc. | Large-cap | Healthcare

$73.29

-0.01%

Cooper Companies vs Intuitive Surgical Cooper Companies vs Becton, Dickinson Cooper Companies vs Alcon Cooper Companies vs ResMed Cooper Companies vs West Pharmaceutical Cooper Companies vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.9B

Gross Profit 2.6B 66.64%

Operating Income 705.7M 18.12%

Net Income 392.3M 10.07%

EPS (Diluted) $1.96

Balance Sheet Metrics

Total Assets 12.3B

Total Liabilities 4.2B

Shareholders Equity 8.1B

Debt to Equity 0.52

Cash Flow Metrics

Operating Cash Flow 678.2M

Free Cash Flow 288.1M

Revenue & Profitability Trend

Cooper Companies Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	3.9B	3.6B	3.3B	2.9B	2.4B
Cost of Goods Sold	1.3B	1.2B	1.2B	966.7M	896.1M
Gross Profit	2.6B	2.4B	2.1B	2.0B	1.5B
Operating Expenses	1.7B	1.6B	1.5B	1.3B	1.1B
Operating Income	705.7M	533.1M	507.6M	505.8M	311.8M
Pre-tax Income	582.3M	412.9M	475.3M	491.5M	266.5M
Income Tax	190.0M	118.7M	89.5M	-2.5B	28.1M
Net Income	392.3M	294.2M	385.8M	2.9B	238.4M
EPS (Diluted)	$1.96	$1.48	$1.94	$14.79	$1.20

Income Statement Trend

Cooper Companies Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	2.0B	1.7B	1.5B	1.5B	1.3B
Non-Current Assets	10.4B	10.0B	10.0B	8.1B	5.5B
Total Assets	12.3B	11.7B	11.5B	9.6B	6.7B
Liabilities
Current Liabilities	1.0B	969.0M	1.3B	732.1M	1.0B
Non-Current Liabilities	3.2B	3.1B	3.0B	1.9B	1.9B
Total Liabilities	4.2B	4.1B	4.3B	2.7B	2.9B
Equity
Total Shareholders Equity	8.1B	7.6B	7.2B	6.9B	3.8B

Balance Sheet Composition

Cooper Companies Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	392.3M	294.2M	385.8M	2.9B	238.4M
Operating Cash Flow	678.2M	486.8M	682.9M	674.5M	490.6M
Investing Activities
Capital Expenditures	-421.2M	-392.5M	-242.0M	-214.4M	-310.4M
Investing Cash Flow	-764.6M	-449.0M	-1.8B	-450.3M	-364.5M
Financing Activities
Dividends Paid	0	-3.0M	-3.0M	-3.0M	-3.0M
Financing Cash Flow	5.6M	-183.8M	1.2B	-337.8M	-94.9M
Free Cash Flow	288.1M	215.0M	450.4M	524.2M	176.2M

Cash Flow Trend

Cooper Companies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 33.58

Forward P/E 17.04

Price to Book 1.67

Price to Sales 3.48

PEG Ratio 17.04

Profitability Ratios

Profit Margin 10.39%

Operating Margin 18.44%

Return on Equity 5.15%

Return on Assets 3.88%

Financial Health

Current Ratio 2.10

Debt to Equity 34.50

Beta 0.99

Per Share Data

EPS (TTM) $2.07

Book Value per Share $41.54

Revenue per Share $19.99

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
coo	13.9B	33.58	1.67	5.15%	10.39%	34.50
Intuitive Surgical	184.6B	75.42	10.79	15.96%	28.41%	0.00
Becton, Dickinson	48.6B	32.89	1.93	5.89%	7.18%	76.34
Alcon	42.8B	38.45	1.95	5.23%	11.28%	23.63
ResMed	37.3B	28.60	6.73	25.81%	26.15%	15.14
West Pharmaceutical	16.0B	34.96	5.96	17.42%	16.13%	11.46

Financial data is updated regularly. All figures are in the company's reporting currency.